X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancer (5) 5
life sciences (5) 5
index medicus (4) 4
peptides (4) 4
antibodies (3) 3
cell proliferation (3) 3
chemistry (3) 3
human necessities (3) 3
hygiene (3) 3
medical or veterinary science (3) 3
metallurgy (3) 3
neuregulin 1 (3) 3
oncology (3) 3
organic chemistry (3) 3
pancreatic cancer (3) 3
preparations for medical, dental, or toilet purposes (3) 3
specific therapeutic activity of chemical compounds ormedicinal preparations (3) 3
tumors (3) 3
xenografts (3) 3
[sdv]life sciences [q-bio] (2) 2
adenocarcinoma (2) 2
akt protein (2) 2
animals (2) 2
biocompatibility (2) 2
biotechnology (2) 2
cancer therapies (2) 2
cancer-associated fibroblast (2) 2
cellular biology (2) 2
chemotherapy (2) 2
clinical trials (2) 2
cytotoxicity (2) 2
expression (2) 2
growth (2) 2
her3 (2) 2
humans (2) 2
immunoglobulins (2) 2
immunology (2) 2
immunotherapy (2) 2
ligands (2) 2
neuregulin (2) 2
phosphorylation (2) 2
toxicity (2) 2
tumor cells (2) 2
viral antibodies (2) 2
xenotransplantation (2) 2
[ sdv ] life sciences [q-bio] (1) 1
[sdv.bc]life sciences [q-bio]/cellular biology (1) 1
[sdv.bio]life sciences [q-bio]/biotechnology (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.imm]life sciences [q-bio]/immunology (1) 1
[sdv.neu]life sciences [q-bio]/neurons and cognition [q-bio.nc] (1) 1
a549 cells (1) 1
abeta (1) 1
acth (1) 1
adc (1) 1
aging (1) 1
allosteric properties (1) 1
alzheimer disease (1) 1
alzheimer's disease (1) 1
amygdala (1) 1
amyloid peptide (1) 1
amyloid-beta (1) 1
analysis (1) 1
anti-erbb3 antibody (1) 1
antibodies, anti-idiotypic - administration & dosage (1) 1
antibodies, anti-idiotypic - immunology (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - immunology (1) 1
anticancer properties (1) 1
antitumor activity (1) 1
apoptosis (1) 1
avp (1) 1
binding (1) 1
biochemistry, molecular biology (1) 1
bioengineering (1) 1
biomarkers (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - immunology (1) 1
biopharmaceutics (1) 1
body regions (1) 1
breast cancer (1) 1
caspase (1) 1
caspase-3 (1) 1
cell behavior (1) 1
cell cycle (1) 1
cell death (1) 1
cell lines (1) 1
cell lung-cancer (1) 1
cell migration (1) 1
cell proliferation - drug effects (1) 1
cell survival (1) 1
chronic stress (1) 1
combination (1) 1
combination therapy (1) 1
competition (1) 1
conflicts of interest (1) 1
conjugates (1) 1
corticosteroids (1) 1
corticosterone (1) 1
corticotropin-releasing hormone (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 7, pp. 1838 - 1851
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2017, Volume 16, Issue 7, pp. 1312 - 1323
Exploratory clinical trials using therapeutic anti-HER3 antibodies strongly suggest that neuregulin (NRG1; HER3 ligand) expression at tumor sites is a... 
CELL LUNG-CANCER | ANTI-ERBB3 ANTIBODY | PREDICTIVE BIOMARKER | ONCOLOGY | RANDOMIZED PHASE-II | COMBINATION THERAPY | GAMMA-HEREGULIN | MONOCLONAL-ANTIBODY | GROWTH-FACTOR | OVARIAN-CANCER | THERAPEUTIC ANTIBODY | Phosphorylation | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Gene Expression Regulation, Neoplastic | Neuregulin-1 - genetics | Antibodies, Anti-Idiotypic - administration & dosage | Neoplasms - genetics | Receptor, ErbB-3 - immunology | Fluorescence Resonance Energy Transfer | Female | A549 Cells | Neuregulin-1 - immunology | Antibodies, Monoclonal, Murine-Derived - immunology | Antibodies, Anti-Idiotypic - immunology | Receptor, ErbB-3 - antagonists & inhibitors | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Neoplasms - immunology | Protein Binding | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Mice | Neoplasms - pathology | Biomarkers, Tumor - immunology | Cell proliferation | Competition | Energy use | Neuregulin 1 | Toxicity | Clinical trials | Antibodies | Fluorescence | Cytotoxicity | AKT protein | Anticancer properties | Allosteric properties | Pancreatic carcinoma | Xenografts | Biocompatibility | Neuregulin | Inhibition | Fluorescence resonance energy transfer | Recombinant | Binding | Medical research | Immunoglobulins | Extracellular signal-regulated kinase | Lungs | Biomarkers | Antitumor activity | Ligands | Energy transfer | Cancer | Tumors
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 05/2013, Volume 34, Issue 5, pp. 1426 - 1439
Elevated cortisol evidence in Alzheimer's disease (AD) patients prompted the hypothesis that stress and glucocorticoids are involved in the development and/or... 
Journal Article
10/2018
The disclosure relates to human anti-NRG1 neutralizing monoclonal antibodies that do not interfere with the NRG1 binding to the HER3 receptor and uses thereof.... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
09/2018
The disclosure relates to human anti-NRG1 neutralizing monoclonal antibodies that do not interfere with the NRG1 binding to the HER3 receptor and uses thereof.... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
05/2017
The disclosure relates to human anti-NRG1 neutralizing monoclonal antibodies that do not interfere with the NRG1 binding to the HER3 receptor and uses thereof.... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
10/2004, Issue 41
The push for Indigenous studies to be included in teacher training is finally getting results, reports Janine Ogier. 
Magazine Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.